BRIEF-Morphosys And Galapagos Present Results From Phase 1 Study With Mor106
February 19, 2018 at 03:04 AM EST
* SAID ON SATURDAY MORPHOSYS AND GALAPAGOS PRESENT RESULTS FROM A PHASE 1 STUDY WITH MOR106 IN ATOPIC DERMATITIS AS LATE-BREAKING ABSTRACT